ARVO 2023: Research on epigenetic reprogramming to reverse aging and restore function to RGCs
April 29th 2023ARVO
Our onsite team spoke with Bruce Ksander, PhD, at the 2023 ARVO annual meeting, where he discussed his presentation about epigenetic reprogramming to reverse aging and restore function to retinal ganglion cells.
ARVO 2023: Carl Danzig, MD, FASRS shares new data on vision loss from the GATHER clinical program
April 25th 2023ARVO
Ophthalmology Times® spoke with Carl Danzig, MD, FASRS, at the 2023 ARVO annual meeting to learn more about the post hoc analysis for the GATHER trials and the new data on the correlation between vision loss and GA growth.
ARVO 2023: Using donor tissue to identify the mechanism cell death of the RPE
April 25th 2023ARVO
Deborah Ferrington, PhD, spoke with on our on-site team at the 2023 ARVO annual meeting in New Orleans about her presentation on using human donor tissue to identify the mechanism responsible for the death of the retinal pigment epithelium (RPE).
ARVO 2023: Luxa Biotechnology shares progress of Phase 1/2a clinical trial for AMD treatment
April 25th 2023ARVO
At ARVO in New Orleans, Luxa Biotechnology shared an update on the progress of a Phase 1/2a clinical trial evaluating transplantation of RPESC-RPE-4W to treat dry age-related macular degeneration (AMD).
ARVO 2023: Association between visual impairment and neuropsychiatric symptoms of dementia
April 24th 2023ARVO
Researchers found in their analysis that visual impairment is associated with hallucinations, depression, agitation, and psychosis in patients with dementia, although, aging and comorbidities, among other factors, may be involved.
ARVO 2023: Nonclinical data by Adverum Biotechnologies regarding potential treatment of wet AMD
April 24th 2023ARVO
Adverum Biotechnologies Inc. shared nonclinical data at ARVO 2023 in New Orleans that staggered, bilateral administration of Ixo-vec in NHPs was well tolerated with encouraging therapeutic activity and no signals of increased inflammation.
ARVO 2023: Ocular blood flow and its relationship to acute coronary syndrome
April 24th 2023ARVO
The team of Japanese researchers found that the choroidal MBR in the nasal region is correlated with systemic arterial stiffness and is significantly lower in patients with coronary artery multivessel disease.